GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
GEVA
Delisted
GEVA was delisted on the 22nd of June, 2015.
115 hedge funds and large institutions have $2.68B invested in SYNAGEVA BIOPHARMA CORP COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
64% less call options, than puts
Call options by funds: $13.9M | Put options by funds: $38.7M
Holders
115
Holding in Top 10
2
Calls
$13.9M
Puts
$38.7M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$31.1M | |
| 3 | +$28.6M | |
| 4 |
DM
Deerfield Management
New York
|
+$26.4M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$22.3M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$22.7M | |
| 3 | -$18.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$12.7M |
| 5 |
FAM
Fred Alger Management
New York
|
-$10.3M |